Related Experiment Videos
Homocysteine: an emergent cardiovascular risk factor?
M A Medina1, M I Amores-Sánchez
1Universidad de Málaga, Málaga, Spain. medina@uma.es
Insights
Mild hyperhomocysteinemia is increasingly recognized as a significant, independent risk factor for cardiovascular disease. This review explores homocysteine metabolism and clinical evidence supporting its role in heart disease development.
Area of Science:
- Biochemistry and Medicine
- Cardiovascular Research
Background:
- Cardiovascular disease is a primary cause of mortality and disability globally.
- Growing evidence suggests mild hyperhomocysteinemia is a key independent risk factor for cardiovascular disease.
Purpose of the Study:
- To review homocysteine's metabolic role.
- To examine the pathogenesis of hyperhomocysteinemia.
- To analyze clinical data linking hyperhomocysteinemia to cardiovascular disease risk.
Main Methods:
- Literature review of retrospective and prospective clinical studies.
- Analysis of homocysteine metabolism pathways.
- Synthesis of clinical data on hyperhomocysteinemia and cardiovascular outcomes.
Main Results:
- Homocysteine plays a crucial role in metabolic pathways.
- Hyperhomocysteinemia is linked to the pathogenesis of cardiovascular disease.
- Clinical studies consistently identify elevated homocysteine levels as an independent risk factor.
Conclusions:
- Mild hyperhomocysteinemia is a significant, independent risk factor for cardiovascular disease.
- Understanding homocysteine metabolism is vital for cardiovascular disease prevention.
- Further research into managing homocysteine levels may reduce cardiovascular disease burden.
Abstract:
Cardiovascular disease is the leading cause of mortality and disability in the western world. In the last years, the accumulation of evidence coming from both retrospective and prospective clinical studies has led to an increased interest in the potential role of mild hyperhomocysteinemia as a major, independent risk factor for cardiovascular disease. The present paper reviews the position of homocysteine in metabolism to understand the pathogenesis of hyperhomocysteinemia, as well as the clinical data pointing to its proposed role as an independent cardiovascular disease risk factor.